Additionally, 92% experienced remission from depression.
Read morePsychiatrists Have Positive Attitude Towards Psychedelics
This recent study shows a striking positive shift in attitudes toward the therapeutic potential of hallucinogens among American psychiatrists since 2016, with a majority of responding psychiatrists planning to incorporate hallucinogen-assisted therapy into their practice if regulatory approval is granted.
Read moreNew Psilocybin Research
This recently published study showed that psilocybin use is associated with persisting improvements in mental health and wellbeing.
Read moreMindfulness and Psychedelics
Psychedelics- An Update
Psychedelic Science 2023 brought together 12,000 registrants in Denver, Colorado, four times as many people as the previous conference in 2017, crowning the movement to rehabilitate psychedelics for therapeutic use against depression and other disorders.
Read moreKetamine For Depression
This ketamine trial for resistant depression shows positive results.
The study is the largest to date comparing generic ketamine with placebo in treating severe depression.
Read morePsychedelic Research, Risks and Benefits
Here a UC researcher discusses how psychedelics show promise for treating PTSD and anxiety, but risks remain.
Read moreChemical Imbalance Theory
Keep reading for the history of the chemical imbalance theory, how a study last year tried to debunk it, and how that study is now seen to be flawed.
Read morePsychological Strengths with Psychedelic Use
The findings, published in the International Journal of Wellbeing, indicate that self-transcendent experiences play a key role in predicting positive outcomes of psychedelic use.
Read moreMicrodosing and Authenticity
A recent study found that on the microdosing day and the day thereafter, state authenticity was significantly higher.
Furthermore, the number of activities and the satisfaction with them were higher on the day when participants microdosed, while the following day only the number of activities was higher.
The researchers propose that feeling and behaving authentically could have a central role in explaining the positive effects of microdosing on health and wellbeing that are reported by their study.
5-MeO-DMT Research
A first patient has been dosed in 5-MeO-DMT for a depression trial.
The trial is being carried out by Beckley Psytech.
Read more